Nov 22, 2024
2024 AGM CEO Presentation
Nov 13, 2024
CTOS 2024 Annual Meeting – EFTISARC-NEO trial of neoadjuvant soluble LAG-3 protein (Soft Tissue Sarcoma)
Sep 15, 2024
ESMO Congress 2024 – TACTI-003, Cohort A (Head and Neck Squamous Cell Carcinoma)
Jul 12, 2024
ESMO Virtual Plenary 2024 – TACTI-003, Cohort B (Head and Neck Squamous Cell Carcinoma)
Jul 11, 2024
Global Webcast Slides for TACTI-003 Positive Data in Patients with Negative PD-L1 Expression (Cohort B)
